Abstract Book

Treatment planning: where are we and, where are we going................................................. (Abs. 641)

Joint Symposium ESTRO-EORTC: New strategies for a clinical research partnership?................................... (Abs. 642-644) Symposium Automatic planning – the challenges for success........................................................... (Abs. 645-648) Advances in normal tissue radiobiology........................................................................ (Abs. 649-651) What is the limit of hypofractionation?......................................................................... (Abs. 652-655) Brain tumors in 2018: are there still unsolved problems?. .............................................. (Abs. 656-658) Advances in MRI simulation (MRI-only treatment planning)............................................. (Abs. 659-661) In vivo dosimetry and online dose verification............................................................... (Abs. 662-664) Advanced planning. .................................................................................................. (Abs. 665-667) Implications of the ageing population for radiation oncology........................................... (Abs. 668-671) Salvage prostate radiotherapy.................................................................................... (Abs. 672-675) Symposium Radiation induced senescence. ................................................................................... (Abs. 676-678) Immunotherapy. ...................................................................................................... (Abs. 679-682) Debate This house believes that stereotactic radiosurgery will replace whole brain radiotherapy in patients with ten brain metastases.......................................................................... (Abs. 683-686) Joint Symposium ESTRO-EFOMP: CBCT in radiotherapy: Improving and sharing best practice...................... (Abs. 687-689) Symposium Dose painting – from bench to bed(?).......................................................................... (Abs. 690-693) Debate Autoplanning, is there still a bright future for RTTs after automation?............................... (Abs. 694-695) Posters Clinical track: Head and Neck..................................................................................... (Abs. 696-710) Clinical track: CNS.................................................................................................... (Abs. 711-729) Clinical track: Haematology........................................................................................ (Abs. 730-737) Clinical track: Breast................................................................................................. (Abs. 738-745) Clinical track: Lung................................................................................................... (Abs. 746-757) Clinical track: Upper GI (oesophagus, stomach, pancreas, liver)...................................... (Abs. 758-788) Clinical track: Lower GI (colon, rectum, anus). ............................................................. (Abs. 789-801) Clinical track: Gynaecological (endometrium, cervix, vagina, vulva)................................. (Abs. 802-815) Clinical track: Prostate.............................................................................................. (Abs. 816-829) Clinical track: Urology-non-prostate............................................................................ (Abs. 831-833) Clinical track: Skin cancer / malignant melanoma.......................................................... (Abs. 834-835) Clinical track: Sarcoma.............................................................................................. (Abs. 836-838) Clinical track: Paediatric tumours................................................................................ (Abs. 839-843) Clinical track: Palliation............................................................................................. (Abs. 844-849) Clinical track: Elderly................................................................................................ (Abs. 850-857) Clinical track: Health services research / health economics............................................. (Abs. 858-859) Clinical track: Other.................................................................................................. (Abs. 860-869) Physics track: Basic dosimetry and phantom and detector development. .......................... (Abs. 870-878) Physics track: Dose measurement and dose calculation.................................................. (Abs. 879-894) Physics track: Radiation protection, secondary tumour induction and low dose (incl. imaging).. (Abs. 895-898) Physics track: Treatment plan optimisation: algorithms.................................................. (Abs. 899-910) Physics track: Treatment planning: applications............................................................ (Abs. 911-928) Physics track: (Radio)biological modelling.................................................................... (Abs. 929-933) Physics track: Intra-fraction motion management.......................................................... (Abs. 934-950) Physics track: Inter-fraction motion management (excl. adaptive radiotherapy)................. (Abs. 951-957) Physics track: Adaptive radiotherapy for inter-fraction motion management...................... (Abs. 958-965) Physics track: CT Imaging for treatment preparation. .................................................... (Abs. 966-971) Physics track: (Quantitative) functional and biological imaging........................................ (Abs. 972-985) Physics track: Images and analyses. ........................................................................... (Abs. 986-991) Physics track: Implementation of new technology, techniques, clinical protocols or trials (including QA and audit).......................................................................................... (Abs. 992-1012) Brachytherapy: Breast. ..........................................................................................(Abs. 1013-1014) Brachytherapy: Gynaecolgy. ...................................................................................(Abs. 1015-1018) Brachytherapy: Head and neck........................................................................................(Abs. 1019) Brachytherapy: Physics..........................................................................................(Abs. 1020-1023) Brachytherapy: Prostate.........................................................................................(Abs. 1024-1028) Brachytherapy: Anorectal. ..............................................................................................(Abs. 1029) Brachytherapy: Miscellaneous. ................................................................................(Abs. 1030-1034) Radiobiology track: Normal tissue biology of the heart Radiobiology track: Normal tissue biology of the lung. ........................................................(Abs. 1035) Radiobiology track: Normal tissue biology of central nervous system.....................................(Abs. 1036)